Research & Peer Review Studies

By partnering with state-of-the-art research laboratories in USA (USP, FDA level laboratory) and Japan, we can continue to invest in the research and innovation of alternative medicines. This research enables us to provide, what we believe, are the best and safest products on the market to our clients, today and in years to come.


The following research information applies only for products manufactured by Kenrico. Any other use of the research information including translation in other languages, without written permission of Kenrico is strictly prohibited and subjected to severe penalty. By viewing the research information under this paragraph, you have agreed to the Terms of Use.


1. NEURO47: THETA BRAINWAVES

March 12 2025
Theta brainwaves analysis

A large scale single blind clinical study to investigate the effects of Sporolife patch in enhancing sleep quality of 1000 subjects.


RESULT: Participants using MEGA GOLD experienced a remarkable +58.20% increase in their optimal transition to sleep. Those using the TRMX 5 50th Anniversary saw a significant +41.47% improvement in their ability to achieve optimal sleep transition. In contrast, subjects using non-Sporolife patches experienced a -40% decrease in sleep transition, highlighting a noticeable decline in sleep quality without the advantages of Sporolife technology.

An interesting discovery revealed notable differences in responses between genders.

Performance Ranking Table


2. CTMED575: CT SCAN DIAGNOSIS WITH X-RAYS

October 1 2022 - December 1 2022
CT Scan Diagnosis with X-Rays

A large scale single blind clinical study utilizing CT scan to explore the effect of Sporolife in changing the blood and lymphatic circulation in human body.


RESULT:
A clinical study confirmed the European Authority's mandatory requirement for Sporolife in the product. The trial showed Sporolife can reduce fat percentage by up to 6% without exercise while improving symptoms like bloating, fatigue, breathlessness, headaches, cramps, and constipation.


3. CTS15: NERVES AND LIGAMENTS

January 15 2021

A clinical study to investigate the effects of TRMX LIFE PLUS on the meridian nerve and transverse carpal ligaments in 1000 subjects with various degree of carpal tunnel syndrome.


RESULT: 86.40% of patients reported full recovery with 5% of patients and 8.60% of patients reported vast improvement to their condition on the 6th week.


4. TR-MED964: 3D NEUROIMAGING WITH EGG AND BLOOD ANALYSIS

July 10 2018 - February 12 2019

A large scale single blind clinical study (200 participants) to investigate the effectiveness of Kenrico Supreme Gold Edition TRMX 4 Original.


RESULT: Sporolife was found to be an essential composition to eliminate lymphedema with symptoms of weight gain, bloating, poisoning, and elevated stress or depression.

5.TR-MED742: EEG BRAINWAVES SYNCH AND ALPHA BRAINWAVES COMPARISON

July 2014 - February 14 2015

A large scale single blind clinical study (200 participants) to investigate the effectiveness of Kenrico Supreme Gold Edition (TRMX-3 30th Anniversary).


RESULT: 19% increase of total alpha brainwaves, 136 nV increase of maximum alpha brainwaves, 11% increase of Sorgi-Einstein index.


6. DEXA02: FAT AND CELLULITE RESEARCH OF DIAMOND HYBRID EDITION DHE

June 2 2013 - July 11 2013

An open trial clinical study examines the effectiveness of The New Diamond Hybrid Edition (DHE) for cleansing toxins and for burning excess fats and cellulite while the body is at rest.


RESULT: The Diamond Hybrid Edition (DHE ®) eliminates excess fats and cellulite (overall -15%, up to -10% on abdomen and -11.3% on legs) within 30 days.


7. DEXA02: NATURAL ENERGY RESEARCH OF DIAMOND HYBRID EDITION DHE

October 27, 2013

Third-party independent laboratory analysis to inspect the medical engineering and to examine the effectiveness of DHE to combat diseases.


RESULT: The Diamond Hybrid Edition (DHE ®) provide the HIGHEST amount of beneficial energy to eliminate toxic accumulation in the body, enlarged fat cells, water retention, fibrosis and all fat-related diseases.


8. DEFENSOR II: PERFORMANCE ANALYSIS

May, 2011 - February 28, 2013

DEFENSOR II, a phase 4 human clinical trial, examines the effectiveness of cures utilizing TRMX-3 for physical & mental stress, depression, heavy metals poisoning, inflammation and pain.


RESULT: The Supreme Gold Edition (TRMX-3 ®) provide powerful effects in boosting health when administered as a short-term or a long-term treatment.


9. LEXIRIN I: APOPTOSIS PREVENTION

October 1 2005 - September 1 2012

Human clinical trial with 300 participants to investigate the effectiveness of The Superior Edition (LEXIRIN) ®.


RESULT: Clinical trial confirmed the positive effects of the Superior Edition (LEXIRIN) in treating gastrointestinal disorders and other wide range of diseases including Alzheimer's disease. LEXIRIN also protects organs and can be used as elixir of life to increase the human lifespan.


10. DEFENSOR I: PERFORMANCE ANALYSIS

February 1 2011 - March 1 2011

Human clinical trial conducted by third-party independent medical clinic, Woking Football Club, United Kingdom.


RESULT: a maximum of 300% of improved performance and winning percentages during the clinical trial with the TRMX-3 ®.


11. HA09: HEAVY METALS REMOVAL EFFICACY

December 5 2008 - March 6 2009

Clinical study conducted by third-party independent research center, Japan Hikari Research Institute.


RESULT: Significant removal of heavy metals from the body after 3 months of continuous use.


12. MR0611: MICROSCOPIC ANALYSIS

June 11 2008

Analysis conducted by third-party independent laboratory, JFR Laboratories to investigate the efficacy of toxins removal utilizing Kenrico Sap Sheet or Detox Pads.


RESULT: Large amount of toxins including heavy metals, excess uric acid, excess oxalic acid are successfully removed.


13. LBA07: LIFESTYLE AND BLOOD ANALYSIS

October 25 2006 - April 25 2007

Clinical study through complete blood test conducted by third-party independent research center, Japan Hikari Research Institute.


RESULT: Noticeable to significant improvement in liver and kidney function, and completely reduced the threat of developing diabetes, gout and infection.


14. LBA06: LDL CHOLESTEROL AND TRIGLYCERIDES REDUCTION

May 30 2006

Clinical study conducted by third-party independent research center and laboratory, Japan Hikari Research Institute, Research Testing Institute and Core Laboratory in USA.


RESULT: Superb reduction to LDL-cholesterol and excess triglycerides to all participants that have borderline to high cholesterol levels.


15. HM02: HEAVY METALS REMOVAL EFFICACY
(ADDITIONAL REPORT)

October 7 2005

Additional report from Japan Hikari Research Institute.


16. HM01: HEAVY METALS REMOVAL EFFICACY

January 18 2005

Clinical study conducted by third-party independent research center, Japan Hikari Research Institute.


RESULT: Successful removal of ALL heavy metals from the body after continuous 3 months of detoxification using Kenrico Sap Sheet or Detox Pads.


17. N04: NEGATIVE IONS ANALYSIS

June 14 2004

Third-party independent analysis conducted by Far Infrared Research Organization.


RESULT: Kenrico Sap Sheet emits the highest amount of negative ions.


18. F04: FAR INFRARED ANALYSIS

June 3 2004

Third-party independent analysis conducted by Far Infrared Research Organization.


RESULT: Improved blood circulation and evidence of far infrared rays from the Kenrico Sap Sheet or Detox Pads. Far infrared originated from Kenrico Sap Sheet is 100% natural & 100% safe, made from natural ingredients, emitted without the help of electric devices.


19. ALPHA03: ALPHA BRAINWAVES

June 6 2003

Clinical study conducted by third-party independent research center, Far Infrared Research Organization.


RESULT: Kenrico Sap Sheet significantly increases alpha brainwave. Alpha brainwaves are conducive to creative problem solving, accelerated learning, mood elevation and stress reduction.


20. SOP49: QUALITY & SAFETY TESTING

June 14 2004

Complete analysis by state-of-the-art research laboratories to test the safety and the quality of Kenrico products.


RESULT: Absolutely free (100% free & safe) of microorganism, germs and pathogens. 100% free of irritant and allergic compounds.


  • NEURO47: THETA BRAINWAVES
    March 3 2025
  • CTMED575: CT SCAN DIAGNOSIS WITH X-RAYS
    October 1 2022 - December 1 2022
  • NERVES & LIGAMENTS: TRMX LIFE PLUS
    January 15 2021
  • 3D NEUROIMAGING: TRMX 4 ORIGINAL
    July 17 2018
  • EEG AND ALPHA: TRMX-3 30th ANNIVERSARY
    July 4 2014 - February 14 2015
  • FAT AND CELLULITE RESEARCH OF DIAMOND HYBRID EDITION DHE
    June 2 2013 - July 11 2013
  • NATURAL ENERGY RESEARCH OF DIAMOND HYBRID EDITION DHE
    October 27 2013
  • DEFENSOR II STUDY OF TRMX-3
    May, 2011 - February 28, 2013
  • LEXIRIN PADS AS ELIXIR OF LIFE
    October 1 2005 - September 1 2012
  • TRMX-3 BOOSTS MENTAL AND PHYSICAL HEALTH
    February 1 2011 - March 1 2011
  • ZEO REMOVES HEAVY METALS
    December 5 2008 - March 6 2009
  • MICROSCOPIC RESEARCH
    June 11 2008
  • LIFESTYLE AND BLOOD ANALYSIS
    October 25 2006 - April 25 2007
  • LDL CHOLESTEROL AND TRIGLYCERIDES REDUCED
    May 30 2006
  • HEAVY METALS RESEARCH (ADDITIONAL REPORT)
    October 7 2005
  • HEAVY METALS RESEARCH
    January 18 2005
  • NEGATIVE IONS RESEARCH
    June 14 2004
  • FAR INFRARED RESEARCH
    June 3 2004
  • BRAIN WAVE RESEARCH
    June 6 2003
  • QUALITY & SAFETY TESTING